Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms

Affiliations

Review

G N Levine et al. N Engl J Med. 1995.

. 1995 Feb 23;332(8):512-21.

doi: 10.1056/NEJM199502233320807.

¹ Evans Memorial Department of Medicine, Boston University School of Medicine, MA.

No abstract available

Comment on

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease.
Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi SJ, Cedarholm JC, Alexander RW. Treasure CB, et al. N Engl J Med. 1995 Feb 23;332(8):481-7. doi: 10.1056/NEJM199502233320801. N Engl J Med. 1995. PMID: 7830728 Clinical Trial.
The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion.
Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P. Anderson TJ, et al. N Engl J Med. 1995 Feb 23;332(8):488-93. doi: 10.1056/NEJM199502233320802. N Engl J Med. 1995. PMID: 7830729 Clinical Trial.